We did this phase 2b study of bactericidal activity -- defined as the decrease in colony forming units ( CFUs ) of Mycobacterium tuberculosis in the sputum of patients with microscopy smear-positive pulmonary tuberculosis-at eight sites in South Africa and Tanzania .